Renovaro - 53 Year Dividend History | RENB
Historical dividend payout and yield for Renovaro (RENB) since 1971. The current TTM dividend payout for Renovaro (RENB) as of December 20, 2024 is $0.00. The current dividend yield for Renovaro as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.279B |
$0.000B |
|
Renovaro Inc. includes RenovaroCube and Renovaro Biosciences. Renovaro Biosciences is an advanced cell-gene-immunotherapy company. Its lead candidate product is a therapeutic vaccine targeting cancers which are difficult to treat including pancreatic and potentially HNC, triple-negative breast cancer, and advanced liver cancer. Renovaro Inc., formerly known as Renovaro Biosciences Inc., is based in LOS ANGELES.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
